A genetic disruption of the microglial MyD88 signaling pathway prevents ECM degradation, preserves neuronal health, and reduces sedation and motor impairment even at high blood alcohol levels, pointing to a neuroimmune mechanism of protection.

Targeting microglial MyD88 signaling could offer a neuroimmune therapeutic strategy to protect the brain from alcohol-induced damage by preserving ECM integrity rather than repairing neurons after damage.

Post-mortem analysis of individuals with severe alcohol use disorder shows similar ECM disruption in the frontal cortex, linking the findings to human AUD.

The work combines in vivo imaging in mice, mechanistic studies of MyD88, and human tissue validation, with publications in Immunity and open-access original research.

Alcohol exposure triggers rapid microglial changes, retracting surveillance branches within an hour and initiating dismantling of the extracellular matrix around neurons.

The study shows microglia actively drive alcohol-induced brain dysfunction, challenging the view that neurons are the sole executors of alcohol’s effects.

ECM degradation disrupts synaptic communication and dampens neuronal activity, leading to sedation and motor impairment, with repeated binge cycles potentially causing irreversible neuronal death in the frontal cortex.

Beyond alcohol, these findings have broader implications for neuroprotection and may inform treatments for other conditions involving microglial activation and ECM disruption.